Resonance Health Limited (ASX:RHT)

Australia flag Australia · Delayed Price · Currency is AUD
0.0380
-0.0070 (-15.56%)
At close: Mar 2, 2026
Market Cap18.13M -3.8%
Revenue (ttm)13.79M +30.2%
Net Income769.30K
EPS0.00
Shares Out477.12M
PE Ratio23.36
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume2,936,839
Average Volume407,537
Open0.0430
Previous Close0.0450
Day's Range0.0380 - 0.0430
52-Week Range0.0330 - 0.0590
Beta1.15
RSI43.84
Earnings DateFeb 26, 2026

About Resonance Health

Resonance Health Limited, a healthcare technology and services company, designs, develops, manufactures, and commercializes software-as-medical devices (SaMD) in the Asia Pacific, North America, Europe, the Middle East, and Africa. It operates through SaMD, Resonance Clinical, and TrialsWest segments. The company offers FerriScan, a non-invasive MRI based solution for quantifying liver iron concentration (LIC); FerriSmart, an artificial intelligence (AI) solution for the automated real-time assessment of LIC; HepaFatScan, a non-invasive MRI-bas... [Read more]

Sector Healthcare
Founded 1987
Employees 16
Stock Exchange Australian Securities Exchange
Ticker Symbol RHT
Full Company Profile

Financial Performance

Financial Statements